tm dna microarray method (CapitalBio Corporation)
Structured Review

Tm Dna Microarray Method, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tm dna microarray method/product/CapitalBio Corporation
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun"
Article Title: GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun
Journal: BMC Infectious Diseases
doi: 10.1186/s12879-018-3131-8
Figure Legend Snippet: CapitalBio™ DNA microarray detection site layout. The contents of the table on the right side correspond to the microarray hybridization dot matrix on the left side in each figure. Every five repeated hybrid grid points correspond to one cell of specific content. QC: surface chemical quality control probe; EC: external control probe for hybridization-based quantitation; BC: blank control; NC: negative control probe; IC: internal control probe for PCR; WT: wild-type. a : Six sites detected in the rpoB gene, Ser531Leu (TCG → TTG), Ser531Trp (TCG → TGG), His526Asp (CAC → GAC), His526Tyr (CAC → TAC), His526Leu (CAC → CTC), His526Arg (CAC → CGC), Leu511Pro (CTG → CCG), Gln513Leu (CAA → CCA), Gln513Lys (CAA → AAA), Asp516Val (GAC → GTC), Asp516Tyr (GAC → TAC), Asp516Gly (GAC → GGC) and Leu533Pro (CTG → CCG), for a total of 13 types of mutants. b : The katG gene and a locus of the inhA gene promoter were tested as isoniazid resistance-related genes. The contents of the table on the right side correspond to the microarray hybridization dot matrix on the left side in each figure. Two katG gene mutants, Ser315Thr (AGC → ACC) and Ser315Asn (AGC → AAC), and one inhA gene promoter mutant, − 15 (C → T) mutant, were identified
Techniques Used: Microarray, Hybridization, Control, Quantitation Assay, Negative Control, Mutagenesis
Figure Legend Snippet: Common results of the CapitalBio™ DNA microarray detection spectra are shown for samples with mutation(s) at a : WT: wild-type. b : NTB: nontuberculous mycobacteria. c : rpoB gene codon 531 (TCG → TTG). d : rpoB gene codon 526 (CAC → TAC). e : katG gene codon 315 (AGC → ACC). f : inhA gene promoter − 15 (C → T)
Techniques Used: Microarray, Mutagenesis
Figure Legend Snippet: Performance evaluation of the CapitalBio™ DNA microarray for rifampin and isoniazid resistance in tuberculosis cases compared with the standard drug sensitivity testing (DST) method for the 671 samples
Techniques Used: Microarray
Figure Legend Snippet: Performance evaluation of the CapitalBio™ DNA microarray for MDR-TB cases compared with the standard drug sensitivity testing (DST) method for the 671 samples
Techniques Used: Microarray
Figure Legend Snippet: Microarray chip detection of mutations in Mycobacterium tuberculosis rpoB-RRDR relevant mutation sites for the 57 samples
Techniques Used: Microarray, Mutagenesis
Figure Legend Snippet: Microarray chip detection of rpoB-RRDR,KatG315 and inhA-15 mutation points for the 121 samples
Techniques Used: Microarray, Mutagenesis